论文部分内容阅读
近年来,慢性再生障碍性贫血(慢再障)的疗效和预后大为改观,但多数缓解所需时间较长,且仍有相当一部分病例应用某一种方法治疗难以出现疗效。1986年以来,我院收治慢再障64例,采用不同治疗方法序贯应用,获得满意效果。现将治疗方法和体会报告如下。 临床资料 一、病例选择 64例均符合1987年宝鸡再障会议修订的全国统一诊断标准,均查酸溶血试验等排除阵发性夜间血红蛋白尿(PNH),部分病例做了骨髓活检证实。64例中男41例,女23例;年龄4～68岁;原发性45例,继发性19例;治疗前病程2个月到23年;外周血象:Hb20～75g/L,WBC(0.8～4.0)×10~9/L,
In recent years, the efficacy and prognosis of chronic aplastic anemia (slow aplastic anemia) have greatly improved, but the majority of the time required for remission is longer, and there is still a considerable number of cases of a particular method of treatment is difficult to effect. Since 1986, our hospital admitted 64 cases of slow aplasia, sequential treatment with different methods of treatment, access to satisfactory results. Now treatment methods and experience report as follows. Clinical data A, the 64 cases were selected in line with the 1987 national standards for the diagnosis of aplastic anemia in patients with aplastic anemia, were investigated acid hemolysis test to exclude paroxysmal nocturnal hemoglobinuria (PNH), in some cases done bone marrow biopsy confirmed. There were 41 males and 23 females in 64 cases, ranging in age from 4 to 68 years old, with 45 cases of primary and 19 cases of secondary. The course of treatment ranged from 2 months to 23 years. The peripheral blood was Hb 20 ~ 75g / L, 0.8 to 4.0) × 10 ~ 9 / L,